Zymeworks (NASDAQ:ZYME) was upgraded by analysts at Wells Fargo & Company from a "hold" rating to a "strong-buy" rating.
Zymeworks (NYSE:ZYME) was upgraded by analysts at Wells Fargo & Company from a "cautious" rating to an "overweight" rating.
Zymeworks (NASDAQ:ZYME) was upgraded by analysts at Citizens Jmp to a "strong-buy" rating.
Zymeworks (NYSE:ZYME) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $32.00 price target on the stock.
Zymeworks (NYSE:ZYME) was given a new $32.00 price target on by analysts at JMP Securities.